 | • レポートコード：QYR2104Z3042 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、免疫レパートリーシーケンシングのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（パイロシーケンシング、ダイターミネーターシーケンシング、半導体シーケンシング、その他）、用途別市場規模（バイオマーカー発見、感染症、ワクチン開発・有効性、癌免疫療法、自己免疫疾患、移植片拒絶反応・耐性、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・免疫レパートリーシーケンシングの市場動向 ・企業の競争状況、市場シェア ・免疫レパートリーシーケンシングの種類別市場規模（パイロシーケンシング、ダイターミネーターシーケンシング、半導体シーケンシング、その他） ・免疫レパートリーシーケンシングの用途別市場規模（バイオマーカー発見、感染症、ワクチン開発・有効性、癌免疫療法、自己免疫疾患、移植片拒絶反応・耐性、その他） ・免疫レパートリーシーケンシングの北米市場規模2016-2027（アメリカ、カナダ） ・免疫レパートリーシーケンシングのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・免疫レパートリーシーケンシングのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・免疫レパートリーシーケンシングの中南米市場規模2016-2027（メキシコ、ブラジル） ・免疫レパートリーシーケンシングの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（ArcherDX、Junom Therapeutics、Roche Holding、Illumina、ThermoFisher Scietific、Pacific Biosciences、CD Genomics、Atreca、Adaptive Biotechnologies） ・結論 |
Immune Repertoire is the collection of B and T cells with functional diversity in the body that reflects the immune selectivity. Immune Repertoire Sequencing means to sequence the complimentary determining region of both B-cell receptor and T-cell receptor. Immune receptor repertoire profiling portrays as the antigen-specific information within lymphocytes and has become increasingly significant to understand body’s autoimmunity and healthy immunity. This also propose novel ways to tackle cancer and development of personalized medicine by understanding the genetic makeup of a person. Since the last two decades, the technical advancements in the high throughput sequencing techniques along with the development in the bioinformatics and statistical tools have made the immune repertoire sequencing to be analyzed at single sequence level. This technology has potential to explore for the novel infectious agents and also offers new approaches for vaccine or antibody development.
Market Analysis and Insights: Global Immune Repertoire Sequencing Market
The global Immune Repertoire Sequencing market size is projected to reach US$ 128.8 million by 2026, from US$ 103.3 million in 2019, at a CAGR of 3.2% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Immune Repertoire Sequencing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Immune Repertoire Sequencing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Immune Repertoire Sequencing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Immune Repertoire Sequencing market.
Global Immune Repertoire Sequencing Scope and Market Size
Immune Repertoire Sequencing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Immune Repertoire Sequencing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Pyro-Sequencing
Dye-Terminating Sequencing
Semiconductor Sequencing
Others
Segment by Application
Biomarker Discovery
Infectious Diseases
Vaccine Development and Efficacy
Cancer Immunotherapy
Autoimmune Disease
Transplant Rejection and Tolerance
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
ArcherDX
Junom Therapeutics
Roche Holding
Illumina
ThermoFisher Scietific
Pacific Biosciences
CD Genomics
Atreca
Adaptive Biotechnologies
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immune Repertoire Sequencing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Pyro-Sequencing
1.2.3 Dye-Terminating Sequencing
1.2.4 Semiconductor Sequencing
1.2.5 Others
1.3 Market by Application
1.3.1 Global Immune Repertoire Sequencing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Biomarker Discovery
1.3.3 Infectious Diseases
1.3.4 Vaccine Development and Efficacy
1.3.5 Cancer Immunotherapy
1.3.6 Autoimmune Disease
1.3.7 Transplant Rejection and Tolerance
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Immune Repertoire Sequencing Market Perspective (2016-2027)
2.2 Immune Repertoire Sequencing Growth Trends by Regions
2.2.1 Immune Repertoire Sequencing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Immune Repertoire Sequencing Historic Market Share by Regions (2016-2021)
2.2.3 Immune Repertoire Sequencing Forecasted Market Size by Regions (2022-2027)
2.3 Immune Repertoire Sequencing Industry Dynamic
2.3.1 Immune Repertoire Sequencing Market Trends
2.3.2 Immune Repertoire Sequencing Market Drivers
2.3.3 Immune Repertoire Sequencing Market Challenges
2.3.4 Immune Repertoire Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immune Repertoire Sequencing Players by Revenue
3.1.1 Global Top Immune Repertoire Sequencing Players by Revenue (2016-2021)
3.1.2 Global Immune Repertoire Sequencing Revenue Market Share by Players (2016-2021)
3.2 Global Immune Repertoire Sequencing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Immune Repertoire Sequencing Revenue
3.4 Global Immune Repertoire Sequencing Market Concentration Ratio
3.4.1 Global Immune Repertoire Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immune Repertoire Sequencing Revenue in 2020
3.5 Immune Repertoire Sequencing Key Players Head office and Area Served
3.6 Key Players Immune Repertoire Sequencing Product Solution and Service
3.7 Date of Enter into Immune Repertoire Sequencing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immune Repertoire Sequencing Breakdown Data by Type
4.1 Global Immune Repertoire Sequencing Historic Market Size by Type (2016-2021)
4.2 Global Immune Repertoire Sequencing Forecasted Market Size by Type (2022-2027)
5 Immune Repertoire Sequencing Breakdown Data by Application
5.1 Global Immune Repertoire Sequencing Historic Market Size by Application (2016-2021)
5.2 Global Immune Repertoire Sequencing Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Immune Repertoire Sequencing Market Size (2016-2027)
6.2 North America Immune Repertoire Sequencing Market Size by Type
6.2.1 North America Immune Repertoire Sequencing Market Size by Type (2016-2021)
6.2.2 North America Immune Repertoire Sequencing Market Size by Type (2022-2027)
6.2.3 North America Immune Repertoire Sequencing Market Size by Type (2016-2027)
6.3 North America Immune Repertoire Sequencing Market Size by Application
6.3.1 North America Immune Repertoire Sequencing Market Size by Application (2016-2021)
6.3.2 North America Immune Repertoire Sequencing Market Size by Application (2022-2027)
6.3.3 North America Immune Repertoire Sequencing Market Size by Application (2016-2027)
6.4 North America Immune Repertoire Sequencing Market Size by Country
6.4.1 North America Immune Repertoire Sequencing Market Size by Country (2016-2021)
6.4.2 North America Immune Repertoire Sequencing Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Immune Repertoire Sequencing Market Size (2016-2027)
7.2 Europe Immune Repertoire Sequencing Market Size by Type
7.2.1 Europe Immune Repertoire Sequencing Market Size by Type (2016-2021)
7.2.2 Europe Immune Repertoire Sequencing Market Size by Type (2022-2027)
7.2.3 Europe Immune Repertoire Sequencing Market Size by Type (2016-2027)
7.3 Europe Immune Repertoire Sequencing Market Size by Application
7.3.1 Europe Immune Repertoire Sequencing Market Size by Application (2016-2021)
7.3.2 Europe Immune Repertoire Sequencing Market Size by Application (2022-2027)
7.3.3 Europe Immune Repertoire Sequencing Market Size by Application (2016-2027)
7.4 Europe Immune Repertoire Sequencing Market Size by Country
7.4.1 Europe Immune Repertoire Sequencing Market Size by Country (2016-2021)
7.4.2 Europe Immune Repertoire Sequencing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Immune Repertoire Sequencing Market Size (2016-2027)
8.2 Asia-Pacific Immune Repertoire Sequencing Market Size by Type
8.2.1 Asia-Pacific Immune Repertoire Sequencing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Immune Repertoire Sequencing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Immune Repertoire Sequencing Market Size by Type (2016-2027)
8.3 Asia-Pacific Immune Repertoire Sequencing Market Size by Application
8.3.1 Asia-Pacific Immune Repertoire Sequencing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Immune Repertoire Sequencing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Immune Repertoire Sequencing Market Size by Application (2016-2027)
8.4 Asia-Pacific Immune Repertoire Sequencing Market Size by Region
8.4.1 Asia-Pacific Immune Repertoire Sequencing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Immune Repertoire Sequencing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Immune Repertoire Sequencing Market Size (2016-2027)
9.2 Latin America Immune Repertoire Sequencing Market Size by Type
9.2.1 Latin America Immune Repertoire Sequencing Market Size by Type (2016-2021)
9.2.2 Latin America Immune Repertoire Sequencing Market Size by Type (2022-2027)
9.2.3 Latin America Immune Repertoire Sequencing Market Size by Type (2016-2027)
9.3 Latin America Immune Repertoire Sequencing Market Size by Application
9.3.1 Latin America Immune Repertoire Sequencing Market Size by Application (2016-2021)
9.3.2 Latin America Immune Repertoire Sequencing Market Size by Application (2022-2027)
9.3.3 Latin America Immune Repertoire Sequencing Market Size by Application (2016-2027)
9.4 Latin America Immune Repertoire Sequencing Market Size by Country
9.4.1 Latin America Immune Repertoire Sequencing Market Size by Country (2016-2021)
9.4.2 Latin America Immune Repertoire Sequencing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immune Repertoire Sequencing Market Size (2016-2027)
10.2 Middle East & Africa Immune Repertoire Sequencing Market Size by Type
10.2.1 Middle East & Africa Immune Repertoire Sequencing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Immune Repertoire Sequencing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Immune Repertoire Sequencing Market Size by Type (2016-2027)
10.3 Middle East & Africa Immune Repertoire Sequencing Market Size by Application
10.3.1 Middle East & Africa Immune Repertoire Sequencing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Immune Repertoire Sequencing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Immune Repertoire Sequencing Market Size by Application (2016-2027)
10.4 Middle East & Africa Immune Repertoire Sequencing Market Size by Country
10.4.1 Middle East & Africa Immune Repertoire Sequencing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Immune Repertoire Sequencing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 ArcherDX
11.1.1 ArcherDX Company Details
11.1.2 ArcherDX Business Overview
11.1.3 ArcherDX Immune Repertoire Sequencing Introduction
11.1.4 ArcherDX Revenue in Immune Repertoire Sequencing Business (2016-2021)
11.1.5 ArcherDX Recent Development
11.2 Junom Therapeutics
11.2.1 Junom Therapeutics Company Details
11.2.2 Junom Therapeutics Business Overview
11.2.3 Junom Therapeutics Immune Repertoire Sequencing Introduction
11.2.4 Junom Therapeutics Revenue in Immune Repertoire Sequencing Business (2016-2021)
11.2.5 Junom Therapeutics Recent Development
11.3 Roche Holding
11.3.1 Roche Holding Company Details
11.3.2 Roche Holding Business Overview
11.3.3 Roche Holding Immune Repertoire Sequencing Introduction
11.3.4 Roche Holding Revenue in Immune Repertoire Sequencing Business (2016-2021)
11.3.5 Roche Holding Recent Development
11.4 Illumina
11.4.1 Illumina Company Details
11.4.2 Illumina Business Overview
11.4.3 Illumina Immune Repertoire Sequencing Introduction
11.4.4 Illumina Revenue in Immune Repertoire Sequencing Business (2016-2021)
11.4.5 Illumina Recent Development
11.5 ThermoFisher Scietific
11.5.1 ThermoFisher Scietific Company Details
11.5.2 ThermoFisher Scietific Business Overview
11.5.3 ThermoFisher Scietific Immune Repertoire Sequencing Introduction
11.5.4 ThermoFisher Scietific Revenue in Immune Repertoire Sequencing Business (2016-2021)
11.5.5 ThermoFisher Scietific Recent Development
11.6 Pacific Biosciences
11.6.1 Pacific Biosciences Company Details
11.6.2 Pacific Biosciences Business Overview
11.6.3 Pacific Biosciences Immune Repertoire Sequencing Introduction
11.6.4 Pacific Biosciences Revenue in Immune Repertoire Sequencing Business (2016-2021)
11.6.5 Pacific Biosciences Recent Development
11.7 CD Genomics
11.7.1 CD Genomics Company Details
11.7.2 CD Genomics Business Overview
11.7.3 CD Genomics Immune Repertoire Sequencing Introduction
11.7.4 CD Genomics Revenue in Immune Repertoire Sequencing Business (2016-2021)
11.7.5 CD Genomics Recent Development
11.8 Atreca
11.8.1 Atreca Company Details
11.8.2 Atreca Business Overview
11.8.3 Atreca Immune Repertoire Sequencing Introduction
11.8.4 Atreca Revenue in Immune Repertoire Sequencing Business (2016-2021)
11.8.5 Atreca Recent Development
11.9 Adaptive Biotechnologies
11.9.1 Adaptive Biotechnologies Company Details
11.9.2 Adaptive Biotechnologies Business Overview
11.9.3 Adaptive Biotechnologies Immune Repertoire Sequencing Introduction
11.9.4 Adaptive Biotechnologies Revenue in Immune Repertoire Sequencing Business (2016-2021)
11.9.5 Adaptive Biotechnologies Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Immune Repertoire Sequencing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Pyro-Sequencing
Table 3. Key Players of Dye-Terminating Sequencing
Table 4. Key Players of Semiconductor Sequencing
Table 5. Key Players of Others
Table 6. Global Immune Repertoire Sequencing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Immune Repertoire Sequencing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Immune Repertoire Sequencing Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Immune Repertoire Sequencing Market Share by Regions (2016-2021)
Table 10. Global Immune Repertoire Sequencing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Immune Repertoire Sequencing Market Share by Regions (2022-2027)
Table 12. Immune Repertoire Sequencing Market Trends
Table 13. Immune Repertoire Sequencing Market Drivers
Table 14. Immune Repertoire Sequencing Market Challenges
Table 15. Immune Repertoire Sequencing Market Restraints
Table 16. Global Immune Repertoire Sequencing Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Immune Repertoire Sequencing Market Share by Players (2016-2021)
Table 18. Global Top Immune Repertoire Sequencing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immune Repertoire Sequencing as of 2020)
Table 19. Ranking of Global Top Immune Repertoire Sequencing Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Immune Repertoire Sequencing Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Immune Repertoire Sequencing Product Solution and Service
Table 23. Date of Enter into Immune Repertoire Sequencing Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Immune Repertoire Sequencing Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Immune Repertoire Sequencing Revenue Market Share by Type (2016-2021)
Table 27. Global Immune Repertoire Sequencing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Immune Repertoire Sequencing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Immune Repertoire Sequencing Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Immune Repertoire Sequencing Revenue Market Share by Application (2016-2021)
Table 31. Global Immune Repertoire Sequencing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Immune Repertoire Sequencing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Immune Repertoire Sequencing Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Immune Repertoire Sequencing Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Immune Repertoire Sequencing Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Immune Repertoire Sequencing Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Immune Repertoire Sequencing Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Immune Repertoire Sequencing Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Immune Repertoire Sequencing Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Immune Repertoire Sequencing Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Immune Repertoire Sequencing Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Immune Repertoire Sequencing Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Immune Repertoire Sequencing Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Immune Repertoire Sequencing Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Immune Repertoire Sequencing Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Immune Repertoire Sequencing Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Immune Repertoire Sequencing Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Immune Repertoire Sequencing Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Immune Repertoire Sequencing Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Immune Repertoire Sequencing Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Immune Repertoire Sequencing Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Immune Repertoire Sequencing Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Immune Repertoire Sequencing Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Immune Repertoire Sequencing Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Immune Repertoire Sequencing Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Immune Repertoire Sequencing Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Immune Repertoire Sequencing Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Immune Repertoire Sequencing Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Immune Repertoire Sequencing Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Immune Repertoire Sequencing Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Immune Repertoire Sequencing Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Immune Repertoire Sequencing Market Size by Country (2022-2027) & (US$ Million)
Table 63. ArcherDX Company Details
Table 64. ArcherDX Business Overview
Table 65. ArcherDX Immune Repertoire Sequencing Product
Table 66. ArcherDX Revenue in Immune Repertoire Sequencing Business (2016-2021) & (US$ Million)
Table 67. ArcherDX Recent Development
Table 68. Junom Therapeutics Company Details
Table 69. Junom Therapeutics Business Overview
Table 70. Junom Therapeutics Immune Repertoire Sequencing Product
Table 71. Junom Therapeutics Revenue in Immune Repertoire Sequencing Business (2016-2021) & (US$ Million)
Table 72. Junom Therapeutics Recent Development
Table 73. Roche Holding Company Details
Table 74. Roche Holding Business Overview
Table 75. Roche Holding Immune Repertoire Sequencing Product
Table 76. Roche Holding Revenue in Immune Repertoire Sequencing Business (2016-2021) & (US$ Million)
Table 77. Roche Holding Recent Development
Table 78. Illumina Company Details
Table 79. Illumina Business Overview
Table 80. Illumina Immune Repertoire Sequencing Product
Table 81. Illumina Revenue in Immune Repertoire Sequencing Business (2016-2021) & (US$ Million)
Table 82. Illumina Recent Development
Table 83. ThermoFisher Scietific Company Details
Table 84. ThermoFisher Scietific Business Overview
Table 85. ThermoFisher Scietific Immune Repertoire Sequencing Product
Table 86. ThermoFisher Scietific Revenue in Immune Repertoire Sequencing Business (2016-2021) & (US$ Million)
Table 87. ThermoFisher Scietific Recent Development
Table 88. Pacific Biosciences Company Details
Table 89. Pacific Biosciences Business Overview
Table 90. Pacific Biosciences Immune Repertoire Sequencing Product
Table 91. Pacific Biosciences Revenue in Immune Repertoire Sequencing Business (2016-2021) & (US$ Million)
Table 92. Pacific Biosciences Recent Development
Table 93. CD Genomics Company Details
Table 94. CD Genomics Business Overview
Table 95. CD Genomics Immune Repertoire Sequencing Product
Table 96. CD Genomics Revenue in Immune Repertoire Sequencing Business (2016-2021) & (US$ Million)
Table 97. CD Genomics Recent Development
Table 98. Atreca Company Details
Table 99. Atreca Business Overview
Table 100. Atreca Revenue in Immune Repertoire Sequencing Business (2016-2021) & (US$ Million)
Table 101. Atreca Recent Development
Table 102. Adaptive Biotechnologies Company Details
Table 103. Adaptive Biotechnologies Business Overview
Table 104. Adaptive Biotechnologies Immune Repertoire Sequencing Product
Table 105. Adaptive Biotechnologies Revenue in Immune Repertoire Sequencing Business (2016-2021) & (US$ Million)
Table 106. Adaptive Biotechnologies Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immune Repertoire Sequencing Market Share by Type: 2020 VS 2027
Figure 2. Pyro-Sequencing Features
Figure 3. Dye-Terminating Sequencing Features
Figure 4. Semiconductor Sequencing Features
Figure 5. Others Features
Figure 6. Global Immune Repertoire Sequencing Market Share by Application: 2020 VS 2027
Figure 7. Biomarker Discovery Case Studies
Figure 8. Infectious Diseases Case Studies
Figure 9. Vaccine Development and Efficacy Case Studies
Figure 10. Cancer Immunotherapy Case Studies
Figure 11. Autoimmune Disease Case Studies
Figure 12. Transplant Rejection and Tolerance Case Studies
Figure 13. Others Case Studies
Figure 14. Immune Repertoire Sequencing Report Years Considered
Figure 15. Global Immune Repertoire Sequencing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Immune Repertoire Sequencing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Immune Repertoire Sequencing Market Share by Regions: 2020 VS 2027
Figure 18. Global Immune Repertoire Sequencing Market Share by Regions (2022-2027)
Figure 19. Global Immune Repertoire Sequencing Market Share by Players in 2020
Figure 20. Global Top Immune Repertoire Sequencing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immune Repertoire Sequencing as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Immune Repertoire Sequencing Revenue in 2020
Figure 22. Global Immune Repertoire Sequencing Revenue Market Share by Type (2016-2021)
Figure 23. Global Immune Repertoire Sequencing Revenue Market Share by Type (2022-2027)
Figure 24. North America Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Immune Repertoire Sequencing Market Share by Type (2016-2027)
Figure 26. North America Immune Repertoire Sequencing Market Share by Application (2016-2027)
Figure 27. North America Immune Repertoire Sequencing Market Share by Country (2016-2027)
Figure 28. United States Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Immune Repertoire Sequencing Market Share by Type (2016-2027)
Figure 32. Europe Immune Repertoire Sequencing Market Share by Application (2016-2027)
Figure 33. Europe Immune Repertoire Sequencing Market Share by Country (2016-2027)
Figure 34. Germany Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Immune Repertoire Sequencing Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Immune Repertoire Sequencing Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Immune Repertoire Sequencing Market Share by Region (2016-2027)
Figure 44. China Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Immune Repertoire Sequencing Market Share by Type (2016-2027)
Figure 52. Latin America Immune Repertoire Sequencing Market Share by Application (2016-2027)
Figure 53. Latin America Immune Repertoire Sequencing Market Share by Country (2016-2027)
Figure 54. Mexico Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Immune Repertoire Sequencing Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Immune Repertoire Sequencing Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Immune Repertoire Sequencing Market Share by Country (2016-2027)
Figure 60. Turkey Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. ArcherDX Revenue Growth Rate in Immune Repertoire Sequencing Business (2016-2021)
Figure 64. Junom Therapeutics Revenue Growth Rate in Immune Repertoire Sequencing Business (2016-2021)
Figure 65. Roche Holding Revenue Growth Rate in Immune Repertoire Sequencing Business (2016-2021)
Figure 66. Illumina Revenue Growth Rate in Immune Repertoire Sequencing Business (2016-2021)
Figure 67. ThermoFisher Scietific Revenue Growth Rate in Immune Repertoire Sequencing Business (2016-2021)
Figure 68. Pacific Biosciences Revenue Growth Rate in Immune Repertoire Sequencing Business (2016-2021)
Figure 69. CD Genomics Revenue Growth Rate in Immune Repertoire Sequencing Business (2016-2021)
Figure 70. Atreca Revenue Growth Rate in Immune Repertoire Sequencing Business (2016-2021)
Figure 71. Adaptive Biotechnologies Revenue Growth Rate in Immune Repertoire Sequencing Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
世界のハイスループットシーケンシング（HTS）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global High-Throughput Sequencing (HTS) Market The global High-Throughput Sequencing (HTS) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data…- 世界のハイスループットシーケンシング（HTS）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global High-Throughput Sequencing (HTS) Market The global High-Throughput Sequencing (HTS) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data…
- 世界の第3世代シーケンス市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Third-Generation Sequencing Market The global Third-Generation Sequencing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity…
- 世界のRNAメチル化シークエンス市場規模・現状・予測（2021年-2027年） RNA methylation is a common phenomenon in both eukaryotes and prokaryotes, which plays a crucial role in regulating multipal biological processes. Antibodies, bisulfite are two most used ingredients to help the sequencing, and contribute to obtain the sequence information and transcripts expression …
- 世界のがんゲノム配列決定市場規模・現状・予測（2021年-2027年） Cancer genome sequencing refers to a method used to identify the complete DNA or RNA sequence of cancer cells based on the sequencing of a single, homogeneous or heterogeneous group of tumor cells. It is a laboratory technique that characterizes DNA or RNA sequences of primary tumor tissue, the tumo…